Seventeen African countries have introduced the vaccine, with 6 to 8 more expected to roll out programs in 2025.
Hyperuricemia was tied to serious complications such as kidney injury, a higher risk of death during or after hospitalization, and long-term cognitive impairment.
Dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine combined with amodiaquine reduced malaria incidence by 94% and 96%, respectively, compared with a control group.
Further tests found seasonal flu, rhinovirus, COVID, and other common respiratory viruses, alongside malaria and complications from malnutrition.
The WHO says it is monitoring some JN.1-related variants, still in low proportions, that might have more immune escape than XEC.
A man from the outbreak area recently died following hemorrhagic fever symptoms, and samples have been sent to Kinshasa for testing.
After problems with earlier samples, a fuller picture of the outbreak is emerging following another round of testing.
An estimated 263 million cases and 597,000 malaria deaths occurred in 2023.
Of 12 samples, 10 were malaria-positive, but officials continue to investigate other contributing factors.
Researchers find partial resistance to artemisinin in 11 of 100 children with complicated malaria.
